Sort
21,453 grants matching “tuberculosis”
ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM IN AIDS
$1,346,097Beth Israel Medical Ctr (New York) · U01 · FY2002 · AI
HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM
$1,344,787University Of Hawaii At Manoa · U01 · FY2001 · AI
MACROPHAGES, DENDRITIC CELLS AND PATHOGENS
$1,344,411Weill Medical College Of Cornell Univ · P01 · FY2004 · AI
Sample Processing Cartridges for Rapid PCR TB Detection
$1,343,564David Alland · Cepheid · R42 · FY2007 · AI
Development of a second generation MDR-XDR TB assay
$1,343,464David Alland · Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2009 · AI
NATURAL HISTORY OF HIV INFECTION IN IVDUS
$1,343,180Montefiore Medical Center (Bronx, Ny) · R01 · FY2001 · DA
Fox COBRE Phase II Admin Core
$1,343,022Joseph M Fox · University Of Delaware · P20 · FY2024 · GM
Phase 2 Pharmacodynamic Study of High-dose Levofloxacin in MDR-TB Treatment
$1,342,713C Robert Horsburgh · Boston University Medical Campus · U01 · FY2014 · AI
DRAMATIC Phase 2 Duration Randomized MDR-TB Treatment Trial
$1,342,487Payam Nahid · University Of California, San Francisco · U01 · FY2022 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE AGREEMENTS
$1,340,770Shea S Rabley · South Carolina Department Of Public Health · U52 · FY2010 · PS
T cell recognition of the MR1 presented microbial metabolome
$1,340,169Erin June Adams · University Of Chicago · R01 · FY2022 · AI
Facility Management, Maintenance and Operation Core
$1,338,439Raymond Paul Goodrich · Colorado State University · UC7 · FY2023 · AI
Immunotherapy to prevent drug-resistant tuberculosis
$1,337,935Rhea N Coler · Access To Advanced Health Institute · R01 · FY2018 · AI
Viable but Nonculturable Mtb
$1,337,354Carl F Nathan · Weill Medical Coll Of Cornell Univ · U19 · FY2016 · AI
MYCOBACTERIUM TUBERCULOSIS (MTB) QUALITY ASSESSMENT PROGRAM (TBQA)
$1,337,240Jeanette Coffin · Midwest Research Institute · N01 · FY2017 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,336,175Kim W Field · Washington State Depart Soc/Hlth Srvs · U52 · FY2007 · PS
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$1,334,665Jim Scioneaux · Louisiana State Office Of Public Health · U52 · FY2008 · PS
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$1,334,664Jim Scioneaux · Louisiana State Office Of Public Health · U52 · FY2009 · PS
RP1: Targeting Beclin 1 complexes for broad-spectrum anti-infective therapeutics
$1,334,248Tiffany Anne Reese · Ut Southwestern Medical Center · U19 · FY2023 · AI
U.T. SOUTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT
$1,331,718University Of Texas Sw Med Ctr/Dallas · U01 · FY2004 · AI
Immunoregulation /Immune Recognition In Filarial/Nonfilarial Parasitic Infection
$1,331,432Thomas Nutman · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
International Research in Korea: Clinical Studies of Drug-Resistant Tuberculosis
$1,331,243Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Integrated University of Puerto Rico Clinical Trials Unit
$1,329,826Carmen D Zorrilla · University Of Puerto Rico Med Sciences · UM1 · FY2016 · AI
Development Of New Chemotherapeutics For Tuberculosis
$1,329,738Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Immune Regulation in Mycobacterial and Fungal Infections
$1,328,731Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI